plaque psoriasis
FDA Approves Oral Treatment for Moderate to Severe Plaque Psoriasis
The approval is based on results from two randomized, double-blinded, placebo-controlled trials.
SEPTEMBER 13, 2022
FDA Approves First Steroid-Free Cream for Plaque Psoriasis
Vtama is an aryl hydrocarbon receptor agonist approved for adults with plaque psoriasis.
MAY 27, 2022
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
JUNE 8, 2018
Load more